BioCentury
ARTICLE | Company News

Management tracks: Editas, Allina Health | Aetna

March 28, 2018 10:09 PM UTC

Genome editing company Editas Medicine Inc. (NASDAQ:EDIT) named James Mullen chairman of the board of directors. He was CEO of Patheon N.V., which Thermo Fisher Scientific Inc. (NYSE:TMO) acquired...